Marina Maria Bellet

Dr. Marina Maria Bellet

Department of Medicine and Surgery, University of Perugia, Perugia, Umbria, Italy
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Immunity
Verified
Journal Article
Closed access
ACAnne M. Curtis
Anne M. Curtis
MBMarina Maria Bellet
Marina Maria Bellet
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi
Luke O'NeillLuke O'Neill
Luke O'Neill

1 November 2010 in Cell Metabolism
Verified
Journal Article
Closed access
Benedetto GrimaldiBenedetto Grimaldi
Benedetto Grimaldi
MBMarina Maria Bellet
Marina Maria Bellet
KSKatada Sayako
Katada Sayako
Giuseppe AstaritaGiuseppe Astarita
Giuseppe Astarita
JHJun Hirayama
Jun Hirayama
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi

28 May 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MBMarina Maria Bellet
Marina Maria Bellet
EDElisa Deriu
Elisa Deriu
JLJanet Z. Liu
Janet Z. Liu
Benedetto GrimaldiBenedetto Grimaldi
Benedetto Grimaldi
CBChristoph Blaschitz
Christoph Blaschitz
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi
Organisms adapt to day–night cycles through highly specialized circadian machinery, whose molecular components anticipate and drive changes in organism behavior and metabolism. Although many effectors of the immune system are known to follow daily oscillations, the role of the circadian clock in the immune response to acute infections is not understood. Here we show that the circadian clock modulates the inflammatory response during acute infection with the pathogen Salmonella enterica serovar Typhimurium ( S. Typhimurium). Mice infected with S. Typhimurium were colonized to higher levels and developed a higher proinflammatory response during the early rest period for mice, compared with other times of the day. We also demonstrate that a functional clock is required for optimal S. Typhimurium colonization and maximal induction of several proinflammatory genes. These findings point to a clock-regulated mechanism of activation of the immune response against an enteric pathogen and may suggest potential therapeutic strategies for chronopharmacologic interventions.

15 November 2010 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
MBMarina Maria Bellet
Marina Maria Bellet
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi
Circadian rhythms regulate a wide variety of physiological and metabolic processes. The clock machinery comprises complex transcriptional–translational feedback loops that, through the action of specific transcription factors, modulate the expression of as many as 10% of cellular transcripts. This marked change in gene expression necessarily implicates a global regulation of chromatin remodeling. Indeed, various descriptive studies have indicated that histone modifications occur at promoters of clock-controlled genes (CCGs) in a circadian manner. The finding that CLOCK, a transcription factor crucial for circadian function, has intrinsic histone acetyl transferase (HAT) activity has paved the way to unraveling the molecular mechanisms that govern circadian chromatin remodeling. A search for the histone deacetylase (HDAC) that counterbalances CLOCK activity revealed that SIRT1, a nicotinamide adenin dinucleotide (NAD+)-dependent HDAC, functions in a circadian manner. Importantly, SIRT1 is a regulator of aging, inflammation and metabolism. As many transcripts that oscillate in mammalian peripheral tissues encode proteins that have central roles in metabolic processes, these findings establish a functional and molecular link between energy balance, chromatin remodeling and circadian physiology. Here we review recent studies that support the existence of this link and discuss their implications for understanding mammalian physiology and pathology.

28 September 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
MSMichelle Seif
Michelle Seif
TKTamara Katharina Kakoschke
Tamara Katharina Kakoschke
FEFrank Ebel
Frank Ebel
MBMarina Maria Bellet
Marina Maria Bellet
NTNora Trinks
Nora Trinks
Juergen LoefflerJuergen Loeffler
Juergen Loeffler
Aspergillus fumigatus is a ubiquitous mold that can cause severe infections in immunocompromised patients, typically manifesting as invasive pulmonary aspergillosis (IPA). Adaptive and innate immune cells that respond to A. fumigatus are present in the endogenous repertoire of patients with IPA but are infrequent and cannot be consistently isolated and expanded for adoptive immunotherapy. Therefore, we gene-engineered A. fumigatus –specific chimeric antigen receptor (Af-CAR) T cells and demonstrate their ability to confer antifungal reactivity in preclinical models in vitro and in vivo. We generated a CAR targeting domain AB90-E8 that recognizes a conserved protein antigen in the cell wall of A. fumigatus hyphae. T cells expressing the Af-CAR recognized A. fumigatus strains and clinical isolates and exerted a direct antifungal effect against A. fumigatus hyphae. In particular, CD8 + Af-CAR T cells released perforin and granzyme B and damaged A. fumigatus hyphae. CD8 + and CD4 + Af-CAR T cells produced cytokines that activated macrophages to potentiate the antifungal effect. In an in vivo model of IPA in immunodeficient mice, CD8 + Af-CAR T cells localized to the site of infection, engaged innate immune cells, and reduced fungal burden in the lung. Adoptive transfer of CD8 + Af-CAR T cells conferred greater antifungal efficacy compared to CD4 + Af-CAR T cells and an improvement in overall survival. Together, our study illustrates the potential of gene-engineered T cells to treat aggressive infectious diseases that are difficult to control with conventional antimicrobial therapy and support the clinical development of Af-CAR T cell therapy to treat IPA.

22 January 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MBMarina Maria Bellet
Marina Maria Bellet
YNYasukazu Nakahata
Yasukazu Nakahata
MBMohamed Boudjelal
Mohamed Boudjelal
EWEmma Watts
Emma Watts
DMDanuta E. Mossakowska
Danuta E. Mossakowska
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi
Circadian rhythms govern a wide variety of physiological and metabolic functions in many organisms, from prokaryotes to humans. We previously reported that silent information regulator 1 (SIRT1), a NAD + -dependent deacetylase, contributes to circadian control. In addition, SIRT1 activity is regulated in a cyclic manner in virtue of the circadian oscillation of the coenzyme NAD + . Here we used specific SIRT1 activator compounds both in vitro and in vivo. We tested a variety of compounds to show that the activation of SIRT1 alters CLOCK:BMAL1-driven transcription in different systems. Activation of SIRT1 induces repression of circadian gene expression and decreases H3 K9/K14 acetylation at corresponding promoters in a time-specific manner. Specific activation of SIRT1 was demonstrated in vivo using liver-specific SIRT1-deficient mice, where the effect of SIRT1 activator compounds was shown to be dependent on SIRT1. Our findings demonstrate that SIRT1 can fine-tune circadian rhythm and pave the way to the development of pharmacological strategies to address a broad range of therapeutic indications.